Moloney Securities Asset Management, LLC Northwest Biotherapeutics Inc Transaction History
Moloney Securities Asset Management, LLC
- $714 Million
- Q3 2024
A detailed history of Moloney Securities Asset Management, LLC transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 462,215 shares of NWBO stock, worth $124,798. This represents 0.02% of its overall portfolio holdings.
Number of Shares
462,215
Previous 424,310
8.93%
Holding current value
$124,798
Previous $182,000
19.23%
% of portfolio
0.02%
Previous 0.03%
Shares
19 transactions
Others Institutions Holding NWBO
# of Institutions
13Shares Held
674KCall Options Held
0Put Options Held
0-
Opus Capital Group, LLC60.2KShares$16,2400.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$9,4500.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$6,3990.0% of portfolio
-
Mai Capital Management20KShares$5,4000.0% of portfolio
-
Lee Danner & Bass Inc20KShares$5,4000.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $280M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...